Wharton Jt

402 total citations
13 papers, 310 citations indexed

About

Wharton Jt is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Wharton Jt has authored 13 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 5 papers in Obstetrics and Gynecology and 4 papers in Immunology. Recurrent topics in Wharton Jt's work include Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Sarcoma Diagnosis and Treatment (2 papers). Wharton Jt is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Sarcoma Diagnosis and Treatment (2 papers). Wharton Jt collaborates with scholars based in United States and United Kingdom. Wharton Jt's co-authors include Rutledge Fn, Fletcher Gh, Jones Hw, Luis Delclos, Gutterman Ju, J. J. Kavanagh, Bryan Fisk, Krakoff Ih, L. Copeland and Felix N. Rutledge and has published in prestigious journals such as American Journal of Roentgenology, International Journal of Gynecology & Obstetrics and PubMed.

In The Last Decade

Wharton Jt

13 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wharton Jt United States 7 176 100 91 67 67 13 310
Allan J. Jacobs United States 9 139 0.8× 100 1.0× 180 2.0× 59 0.9× 36 0.5× 19 321
K.J. Lohe Germany 11 222 1.3× 62 0.6× 98 1.1× 83 1.2× 174 2.6× 28 382
K Weghaupt Germany 6 188 1.1× 106 1.1× 101 1.1× 51 0.8× 64 1.0× 55 293
Ferdinando Coronetta Italy 7 392 2.2× 107 1.1× 214 2.4× 113 1.7× 181 2.7× 11 495
A. H. Tulusan Germany 9 108 0.6× 79 0.8× 54 0.6× 73 1.1× 78 1.2× 28 276
Boyes Da 7 122 0.7× 125 1.3× 224 2.5× 69 1.0× 73 1.1× 18 342
H.W.H.M. van der Putten Netherlands 11 228 1.3× 61 0.6× 166 1.8× 101 1.5× 101 1.5× 16 406
Petra Biewenga Netherlands 7 186 1.1× 49 0.5× 64 0.7× 67 1.0× 91 1.4× 7 347
Anna Dańska-Bidzińska Poland 11 175 1.0× 104 1.0× 190 2.1× 79 1.2× 99 1.5× 42 405
Sang‐Young Ryu South Korea 10 280 1.6× 117 1.2× 168 1.8× 106 1.6× 141 2.1× 21 440

Countries citing papers authored by Wharton Jt

Since Specialization
Citations

This map shows the geographic impact of Wharton Jt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wharton Jt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wharton Jt more than expected).

Fields of papers citing papers by Wharton Jt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wharton Jt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wharton Jt. The network helps show where Wharton Jt may publish in the future.

Co-authorship network of co-authors of Wharton Jt

This figure shows the co-authorship network connecting the top 25 collaborators of Wharton Jt. A scholar is included among the top collaborators of Wharton Jt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wharton Jt. Wharton Jt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fisk, Bryan, et al.. (1997). Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides.. PubMed. 17(1A). 45–53. 37 indexed citations
2.
Gershenson, D. M., et al.. (1991). Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysis. International Journal of Gynecology & Obstetrics. 36(1). 79–79. 2 indexed citations
3.
Jt, Wharton, et al.. (1989). Increased ovarian tumor cell surface reacting antibodies in patients with ovarian adenocarcinoma after viral oncolysate treatment.. PubMed. 9(1). 81–6. 6 indexed citations
4.
Gershenson, D. M., et al.. (1989). Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapy. International Journal of Gynecology & Obstetrics. 30(2). 196–196. 1 indexed citations
5.
Copeland, L., et al.. (1987). The significance of residual tumor after preoperative pelvic irradiation for stage II endometrial carcinoma.. PubMed. 70(6). 916–9. 3 indexed citations
6.
Jt, Wharton, et al.. (1987). Androgen therapy in the treatment of refractory epithelial ovarian cancer.. PubMed. 71(5). 537–8. 12 indexed citations
7.
Jt, Wharton, et al.. (1986). Tamoxifen in the treatment of refractory adenocarcinoma of the cervix.. PubMed. 70(7). 923–4. 2 indexed citations
8.
Jt, Wharton, et al.. (1984). Continuous-infusion vinblastine for treatment of refractory epithelial carcinoma of the ovary: a phase II trial.. PubMed. 68(11). 1417–8. 4 indexed citations
9.
Copeland, L., et al.. (1984). Intermittent Iv homoharringtonine for the treatment of refractory epithelial carcinoma of the ovary: a phase II trial.. PubMed. 68(12). 1503–4. 9 indexed citations
10.
Ju, Gutterman, et al.. (1983). Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.. PubMed. 2(2). 133–8. 23 indexed citations
11.
Jt, Wharton, et al.. (1982). A cancer detection and education program for employees.. PubMed. 83. 265–74. 1 indexed citations
12.
Jt, Wharton, et al.. (1977). Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix.. PubMed. 49(3). 333–8. 160 indexed citations
13.
Delclos, Luis, et al.. (1976). Irradiation of endometrial cancer in patients with medical contraindication to surgery or with unresectable lesions. American Journal of Roentgenology. 126(1). 148–154. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026